- Poster presentation
- Open Access
LTP sensitization and clinical features: diagnostic role of microarray tool
© Ferlisi et al; licensee BioMed Central Ltd. 2011
- Published: 12 August 2011
- Eosinophil Count
- Food Allergen
- Clinical Pattern
The use of the microarray tool is an essential advantage in the allergy diagnosis process in patients with multiple sensitizations showing clinical patterns attributable to the underlying cross-reaction to a single or multiple panallergen. Among panallergens LTP is a thermostable and resistant to pepsin digestion allergen. This features makes it a potent food allergens and explains the frequent development of systemic symptoms.
Identify the allergen source which is causing complex clinical patterns in pediatric patients with multiple sensitizations.
We studied 11 oupatients children (M 6 F 5, mean age10,45 years, range 6-17 years) with multiple sensitizations and high degree of severity of systemic manifestations: 4 patients had generalized urticaria, 5 patients had angioedema, and 2 patients had anaphylaxis. All children filled a questionnaire related to the personal history of allergy and underwent to the SPT with commercial extracts and fresh food. The in vitro test were performed to assess the total IgE, eosinophil count and to search the specific IgE recombinant allergenic molecules with microarray technique.
The most significant result is the finding of sensitization to the family of panallergens LTP in 7 of 11 patients. In the majority of patiens (63.6%) with high severity of clinical manifestation, e.i. anaphylaxis and generalized urticaria the LTP sensitization was the only allergen source confirming the role of this molecule in the cross-reaction mechanism.
This study provided us a good information in the diagnostic evaluation process of pediatric patients with allergic multiple sensitizations and serious clinical patterns in order to plan in real life the long-term management considering the applicability of preventive measure.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.